Difficulty: Medium
Average Score: 94%
Practice
A 55-year-old woman with insulin-dependent diabetes of 40 years' duration complains of severe bloating and abdominal distress, especially after meals. Evaluation is consistent with diabetic gastroparesis. The prokinetic drug you would be most likely to recommend is
Correct answer
D
Rationale
In this scenario, the most appropriate prokinetic drug to recommend for a patient with diabetic gastroparesis is Metoclopramide (option D). Metoclopramide is a dopamine receptor antagonist that enhances gastrointestinal motility by stimulating the muscles in the upper gastrointestinal tract. This action helps to alleviate symptoms of delayed gastric emptying, such as bloating and abdominal distress, which are common in gastroparesis.
Option A, Granisetron, is a 5-HT3 receptor antagonist commonly used to prevent chemotherapy-induced nausea and vomiting, not for enhancing gastrointestinal motility in gastroparesis. Option B, Cimetidine, is an H2 receptor antagonist used for reducing stomach acid production in conditions like ulcers and gastroesophageal reflux disease, not for improving gastric motility. Option C, Droperidol, is an antipsychotic and antiemetic medication not typically used for treating gastroparesis.
Educationally, understanding the mechanism of action of prokinetic drugs like Metoclopramide is crucial for healthcare providers when managing patients with gastrointestinal motility disorders. It is important to tailor the treatment to the specific condition and select the most appropriate medication based on its pharmacological properties to achieve optimal outcomes for the patient.
Option A, Granisetron, is a 5-HT3 receptor antagonist commonly used to prevent chemotherapy-induced nausea and vomiting, not for enhancing gastrointestinal motility in gastroparesis. Option B, Cimetidine, is an H2 receptor antagonist used for reducing stomach acid production in conditions like ulcers and gastroesophageal reflux disease, not for improving gastric motility. Option C, Droperidol, is an antipsychotic and antiemetic medication not typically used for treating gastroparesis.
Educationally, understanding the mechanism of action of prokinetic drugs like Metoclopramide is crucial for healthcare providers when managing patients with gastrointestinal motility disorders. It is important to tailor the treatment to the specific condition and select the most appropriate medication based on its pharmacological properties to achieve optimal outcomes for the patient.